Skip to main content
. 2020 Aug 29;17(15):2387–2395. doi: 10.7150/ijms.48615

Table 1.

The expression of CHD1L in normal ovaries and in benign and malignant epithelial ovarian tumorsa

All cases CHD1L protein
Normal expression Overexpression
Normal ovaries 30 30 (100%) 0 (0)
Cystadenomas 35 33 (94%) 2 (6%)
Borderline tumors 40 35 (87%) 5 (13%)
Invasive carcinomas 160 75 (47%) 85 (53%)

a Values are n (%). A significant increasing frequency of intensive expression of CHD1L was observed in cystadenomas, in borderline tumors and in invasive carcinomas (P<0.01, Chi-Square Test for Trend).